We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adipocytokines and Polycystic Ovary Syndrome (PCOS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00975832
First Posted: September 11, 2009
Last Update Posted: September 11, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Statens Serum Institut
Aarhus University Hospital
Information provided by:
Hvidovre University Hospital
  Purpose
Inflammation may play a role in the development of polycystic ovary syndrome (PCOS). In this study, the investigators investigated the expression of different mediators of inflammation in fatty tissue and in blood in women with and without PCOS.

Condition
Polycystic Ovary Syndrome

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Adipose Expression of Leptin, Adiponectin and IL-6, and Plasma Levels of Adipocytokines in Lean and Obese Women With PCOS

Resource links provided by NLM:


Further study details as provided by Hvidovre University Hospital:

Enrollment: 60
Groups/Cohorts
women with polycystic ovary syndrome
women without polycystic ovary syndrome
women from 18-40 years of age

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
36 women (17 lean and 19 obese)with PCOS and 24 (8 lean and 16 obese) control women
Criteria

Inclusion Criteria:

  • Women with PCOS were included according to the Rotterdam diagnostic criteria for PCOS. Control women met none of the criteria for PCOS

Exclusion Criteria:

  • Oc´s within the last three months, or other medication known to alter glucose/insulin metabolism
  • Other known chronic diseases
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Pernille Fog Svendsen, MD, Copenhagen University Hospital, Hvidovre
ClinicalTrials.gov Identifier: NCT00975832     History of Changes
Other Study ID Numbers: PSvendsen
First Submitted: September 10, 2009
First Posted: September 11, 2009
Last Update Posted: September 11, 2009
Last Verified: September 2009

Keywords provided by Hvidovre University Hospital:
The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines

Additional relevant MeSH terms:
Syndrome
Polycystic Ovary Syndrome
Disease
Pathologic Processes
Ovarian Cysts
Cysts
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases